Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-12-18
1997-09-09
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514546, 514548, 514573, 514684, 514712, 514717, 514719, 560 53, 560 60, 560255, 562452, 568330, 568631, A61K 31557, C07C 5946, C07C 69608
Patent
active
056657730
ABSTRACT:
Disclosed is the use of cloprostenol and fluprostenol analogues for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
REFERENCES:
patent: 3954881 (1976-05-01), Bowler
patent: 4256745 (1981-03-01), Skuballa et al.
patent: 4321275 (1982-03-01), Bowler et al.
patent: 4599353 (1986-07-01), Bito
Coleman et al.,"Prostanoids and their Receptors," Comprehensive Medicinal Chemistry, vol. 3, 12.11:643-714. (1990).
Narumiya et al., "Structure and function of prostanoid receptors," J. of Lipid Mediators, 6:155-161 (1993).
Woodward et al., "Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies," J. of Lipid Mediators, 6:545-553 (1993).
Bito et al., "The ocular effects of prostaglandins and the therapeutic potential of anew PGF.sub.2.alpha. analog, PhXA41 (latanoprost), for glaucoma management," J. of Lipid Mediators, 6:535-543 (1993).
Resul et al., "Phenyl-Substituted Prostaglandins: Potent and Selective Antiglaucoma Agents," J. Med. Chem., 36:243-248 (1993).
Stjernschantz et al., "Phenyl substituted prostaglandin analogs for glaucoma treatment," Drugs of the Future, 17(8):691-704 (1992).
Zajaez et al., "Effect on Human Eye of Prostaglandin and a Prostaglandin Analogue Used to Induce Abortion," IRCS Medical Science: Clinical Medicine: Clinical Pharmacology & Therapeutics: Drug Metabolism & Toxicology: The Eye: Reproduction, Obstetrics & Gynecology, 4:316 (1976).
The Merck Index, 11th Edition, pp. 375, 656 and 657. 1989.
Bishop John E.
Klimko Peter G.
Sallee Verney L.
Zinke Paul W.
Alcon Laboratories Inc.
Arno James A.
Copeland Barry L.
Raymond Richard L.
LandOfFree
Cloprostenol and fluprostenol analogues and their use to treat g does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloprostenol and fluprostenol analogues and their use to treat g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloprostenol and fluprostenol analogues and their use to treat g will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-70667